- Poland
- /
- Capital Markets
- /
- WSE:NVG
Novavis Group Third Quarter 2024 Earnings: zł0.037 loss per share (vs zł0.005 loss in 3Q 2023)
Novavis Group (WSE:NVG) Third Quarter 2024 Results
Key Financial Results
- Revenue: zł201.0k (down 88% from 3Q 2023).
- Net loss: zł1.34m (loss widened by zł1.17m from 3Q 2023).
- zł0.037 loss per share (further deteriorated from zł0.005 loss in 3Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Novavis Group Earnings Insights
Looking ahead, revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Capital Markets industry in Europe.
Performance of the market in Poland.
The company's shares are down 2.4% from a week ago.
Risk Analysis
It is worth noting though that we have found 3 warning signs for Novavis Group (1 shouldn't be ignored!) that you need to take into consideration.
Valuation is complex, but we're here to simplify it.
Discover if Novavis Group might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About WSE:NVG
Novavis Group
Engages in developing, designing, and executing renewable energy sources projects in Poland.
Exceptional growth potential with mediocre balance sheet.